Dr. Grossman’s Blog

Stemedica Cell Technologies, a manufacturer of adult stem cells, has entered into a collaboration agreement with Lumenis, Ltd. to implement a first-of-its-kind, comprehensive clinical study for the treatment of AMD using Stemedica’s MCT (Multiple Cell Technology) adult stem cells and the Lumenis SRT Laser. The clinical study will be conducted at the Fyodorov Eye Institute in Moscow, Russia, regarded as a global leader in treating ocular diseases; a parallel study will occur at Hospital Angeles in Tijuana, Mexico. The year-long study will begin in March.